John P. Brancaccio

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Monmouth Junction, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Brancaccio
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John P. Brancaccio

Form 4 holding Former Director

Cardiff Oncology, Inc.

Security class
Stock Options
Shares / value
125,317
Estimated value
$325,824
Report date
09 Jun 2022
Price
$2.60
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

OKYO Pharma Ltd

Security class
Option
Shares / value
138,394
Estimated value
Report date
08 Jun 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chairman, Director

Hepion Pharmaceuticals, Inc.

Security class
Stock Options
Shares / value
99,563
Estimated value
Report date
19 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John P. Brancaccio

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .